TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 7.90nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 10nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 7.90nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 50nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 32nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 100nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 1.26E+3nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 158nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 1.60nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 126nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: <1.00E+5nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 10nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 398nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 16nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 4nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 2nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 0.200nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 1.30nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 0.398nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 126nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 7.90nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 40nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 1.60nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 0.200nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 0.794nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 0.251nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 200nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 50nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 2.5nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 6.30nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 5nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 4nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 1.60nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 10nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 2nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 1nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 1nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 1nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 0.501nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 0.251nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 0.251nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 7.90nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 1.60nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 0.501nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 2.5nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 0.398nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 2.5nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 32nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 1.60nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair
TargetFusion glycoprotein F0(Human respiratory syncytial virus)
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Janssen Pharmaceutical Companies of Johnson & Johnson
Curated by ChEMBL
Affinity DataEC50: 0.501nMAssay Description:Inhibition of GFP-fused RSV 224 fusion protein infected in human HeLa cells assessed as reduction in viral replication after 3 days by laser microsco...More data for this Ligand-Target Pair